GL1X · GenesisL1 explorer

Research workbench

Kynurenine aminotransferase II inhibitors

Analyse Kynurenine aminotransferase II inhibitors in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4GEB
Type
protein
Length
856 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
KYNURENINE/ALPHA-aminoadipate aminotransferase, mitochondrial
EC
2.6.1.39, 2.6.1.7
UniProt
Q8N5Z0
Ligands
0LD, SO4
Pockets
8 · best druggability 0.76

Structure

x-ray diffraction · 1 distinct chain · 44% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BKYNURENINE/ALPHA-aminoadipate aminotransferase, mitochondrial (EC 2.6.1.39, 2.6.1.7)protein42844% helix, 17% strandQ8N5Z0

Ligands and binding sites

  • 0LD · (5-hydroxy-4-{[(7-hydroxy-6-oxo-2-phenyl-6,7-dihydro-2H-pyrazolo[3,4-b]pyridin-5-yl)amino]methyl}-6-methylpyridin-3-yl)methyl dihydrogen phosphate · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16560.760.82690LD
26150.750.81770LD
32820.680.8332empty
41680.530.7925empty
51420.480.7824empty

Interfaces

1 interface between chains.

  • A–B · 4396 Ų buried · 68 hydrogen bonds · protein-protein

Compared structures

  • 4GEB · Kynurenine Aminotransferase II Inhibitors · the same entry in another collection · chain A against A, TM-score 1.00
  • Q8N5Z0 · AlphaFold monomer V2.0 prediction for KYNURENINE/ALPHA-aminoadipate aminotransferase… · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.